Evidence map›Paper›PMID 40788132›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

In Vitro Monitoring of Babesia microti Infection Dynamics in Whole Blood Microenvironments.

Chao Li, Emily G Bache, Amy L Apgar, Danielle M Tufts, Tagbo H R Niepa

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Acquired motility ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. In Vitro Monitoring of Babesia microti Infection Dynamics in Whole Blood Microenvironments.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
4 · The record

Corrections and comments

  • Update of
    2025
5 · Who and what money

Authors and funding

5 authors.

Chao LiDepartment of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA, 15213, USA.
Emily G BacheDepartment of Infectious Diseases and Microbiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
Amy L ApgarDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA, 15213, USA.
Danielle M TuftsDepartment of Infectious Diseases and Microbiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
Tagbo H R NiepaDepartment of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA, 15213, USA.ORCID https://orcid.org/0000-0002-3018-5419

Funding

DESIGNING A HIGH-THROUGHPUT PLATFORM TO BIOPROSPECT THE HUMAN MICROBIOME AND MANIPULATE ITS INTERPLAY WITH HOST ENVIRONMENTSDP2GM149553 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI NIEPA, TAGBO HERMAN ROLAND · 2022 to 2025
$1.9M
National Science Foundation Graduate Research Fellowship Program DGE2140739NIGMS NIH HHS 7DP2GM149553-02NIGMS NIH HHS DP2 GM149553
6 · The paper itself

Abstract

Babesiosis - a globally emerging tick-borne infectious disease primarily caused by the intraerythrocytic piroplasm parasite, Babesia microti - has traditionally been studied using animal models such as mice. Compared to animal models, microfluidic-based models offer advantages, including direct analysis of human samples (such as patient blood), enhanced assay capacity (including physical/optical access, consistency, and throughput), low costs, and easy adoption. Here, an open microfluidic platform named "µ-Blood" is reported for real-time continuous monitoring B. microti infection dynamics in vitro. Compared to other microfluidic-based models, µ-Blood allows direct examination of infected and uninfected whole blood without preprocessing steps like blood dilution or cell isolation, minimizing observer artifacts and preserving the natural whole blood microenvironment. The system enables extended (72 h) monitoring of infection dynamics, including parasite identification, parasitemia measurement, and parasite-host cell interactions, using label-free phase contrast and fluorescence confocal microscopy. With its open microfluidic configuration, µ-Blood provides an in vitro model for studying blood-borne infection dynamics while maintaining integrity of the whole blood microenvironment.

Indexed as

Babesia microtiBabesiosisAnimalsHost-Parasite InteractionsHumansMiceMicrofluidicshuman babesiosismouse modelopen microfluidicsprotozoan parasitered blood cellstick‐borne pathogen

Identifiers

PMID40788132
PMCPMC12591138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.